Ask AI
Hodkin Lymphoma Frontline Tx

CME

Personalized Pathways: Redefining Frontline Hodgkin Lymphoma Treatment Strategies

Physicians: Maximum of 0.50 AMA PRA Category 1 Credit

Released: July 18, 2025

Expiration: January 17, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A 69-yr-old man is newly diagnosed with stage IIIB cHL. He has an ECOG performance status score of 1, history of mild chronic obstructive pulmonary disease, and an ejection fraction of 60%. He has no contraindications to immunotherapy but is at increased risk for bleomycin-induced pulmonary toxicity. He expresses a preference to avoid regimens with high long-term toxicity risk and is open to novel therapies

Which frontline treatment option would you choose for this patient?

2.

Which frontline treatment would you recommend for a 28-yr-old woman with advanced-stage cHL, a history of inflammatory bowel disease, and strong concerns about preserving fertility?